# A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

> **NCT02597465** · PHASE3 · WITHDRAWN · sponsor: **Sun Pharma Advanced Research Company Limited**

## Conditions studied

- Advanced Biliary Tract Cancer

## Interventions

- **DRUG:** SPARC1507
- **DRUG:** Reference1507

## Key facts

- **NCT ID:** NCT02597465
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-12-01
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decided not to initiate the study for alternate commercial strategy
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02597465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02597465, "A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02597465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*